i tink u know

https://www.bitchute.com/video/ghODiaiNrLdw/ Latypova at 16:30 of video explains a few key things concerning the bioweapon. The main thing is that only a handful at the top of big pharma companies, only a few at the top of gov. agencies KNEW it was all deception/stealth/hell, sterialization, cancer-inducing, death and so forth. The vast majority at the production scene did not know. (Historically, not so many knew Lenin and Stalin were deceivers early; few knew FDR was handing over East Europe to Stalin in early 1945; few knew of the Jekyll Island cabal of 1910 or of the major assassinations. Stealth and deception are very high priorities for these schemes. Same with 9-11, same with IBM and the Holocaust by Black in 2000. -r. Here is an informative Dr. Jane Ruby video dealing with the lot numbers in code from big pharma :https://www.bitchute.com/video/s0noVEjI3dkY/

ionizing radiation and modified-RNA

Ionizing radiation is used in a wide variety of fields such as medicine, nuclear power, research, and industrial manufacturing, but presents a health hazard if proper measures against excessive exposure are not taken. Exposure to ionizing radiation causes cell damage to living tissue and organ damage. In high acute doses, it will result in radiation burns and radiation sickness, and lower level doses over a protracted time can cause cancer.[5][6] https://en.wikipedia.org/wiki/Ionizing_radiation ……………........................…

(Natural News) In today’s exclusive analysis we detail how cobalt-60 dirty bombs unleash a low level of radioactive contamination in the affected area. This radiation is not intense enough to kill people from simple radiation exposure, but when combined with the mRNA “vaccines” and their spike protein suppression of the NHEJ chromosomal repair mechanism in cell nuclei even a low level of radiation could set off a cancer death wave by initiating genetic mutations in the bodies of victims. Stated another way, people who took mRNA vaccines are walking time bombs of cancer since the presence of the spike protein achieves around a 90% suppression of double strand break (DSB) chromosomal repair capability, meaning that any source of ionizing radiation could set off widespread cancer tumor growth. This ionizing radiation can come from excessive sunlight exposure, mammograms, high altitude commercial flights or even dirty bombs that unleash a low level of ionizing radiation. See my November, 2021 article, Only PUREBLOODS will survive the vaccine / radiation holocaust being unleashed against humanity… the spike protein in vaccines causes genetic DISINTEGRATION. The NNSA is currently running dirty bomb drills in Austin, Texas. Code-named, “Cobalt Magnet 22,” the dirty bomb drills are the US government’s response to the intel that radicalized Islamic extremists from Afghanistan have teamed up with explosive vest engineers from Iran, trafficking suicide bomb operators through the refugee exfil routes in Ukraine in order to achieve EU documentation and refugee status. From there they fly to the US and meet up with smugglers who use the non-secured US border to deliver explosive vests which can be disassembled before the border crossing, then reassembled on the US side and combined with radioisotope material. Dirty bomb material such as cobalt-60 — with a half life of 5.27 years, meaning it contaminates the affected area for 53 years (ten half-lives) — is then integrated into the explosive suicide vests in order to achieve high dispersion of radioactive material in the affected area. This radioactive material is not large enough to kill victims with raw radiation exposure. Rather it is designed to contaminate major US cities and spread fear and panic about “nuclear terrorism” which has never before taken place in the USA. US government officials fully realize that radical Islamic terrorists intend to pull off these dirty bombs in targeted US cities, but they are missing a far more important point: Due to the mass vaccination status of the population people are highly vulnerable to cancers caused by low-level exposure to ionizing radiation that is far below any “lethal” dose. What the anti-west terrorists in Afghanistan and Iran have figured out is that western nations have very high mRNA injection rates due to extreme pro-vaccine propaganda pushed by their governments. Further, those vaccine uptake rates are the highest in the cities of those nations where populations tend to be far more obedient and Socialist, which is directly correlated with the “sheeple” mindset that results in oblivious masses agreeing to be injected with spike protein bioweapons platforms known as “vaccines.” This is especially true in the left-wing Socialist cities of Western Europe such as London, Paris, Berlin, etc. Thus strategic enemies of the West have come to realize that even a low level of radiation would, over time, wipe out the vast majority of the population in those cities by unleashing an aggressive wave of cancer caused by chronic, low-level radiation exposure. Dirty bomb material such as cobalt-60 achieves chromosomal breaks due to its ionizing radiation. This well-known fact has no doubt been well understood by the enemies of the West. At the same time those individuals who rejected the experimental bioweapons shots have maintained their innate DNA repair mechanism known as NHEJ. This means unvaccinated individuals can handle low-level exposure to ionizing radiation because they can automatically repair the double strand breaks. Whereas again, vaccinated individuals have largely lost this capability (NHEJ suppression is around 90% according to published studies). The study documenting all this was published in the MDPI journal “Viruses” and was carried out by scientists at Stockholm University, Sweden: https://doi.org/10.3390/v13102056 The study shows that NHEJ efficiency collapses in the presence of the mRNA covid vaccine spike protein. Understand that the goal of dirty bomb terrorism is to spread fear and terror while making large areas uninhabitable due to low-level radiation contamination. It is critical to understand that the mass of cobalt-60 which could be theoretically dispersed from a kinetic explosive vest detonated in a major US city is likely not a sufficient amount to render the area truly dangerous for those with limited exposure such as decontamination crews or people who happened to be within a few miles of the detonation. Rather, the material being dispersed creates a significant hazard for longterm habitation in the area. This in turn will require an evacuation of the area and a military-style lockdown of the affected region since it would not be safe for anyone to live in the area until decontamination is complete (which could take several months). The disruptive impact of this evacuation and lockdown — combined with the psychological impact of such an event taking place in the continental USA — achieves the true “costs” of this attack. It’s not the direct kills, it’s the widespread panic, disruption and economic losses that follow it…. The mainstream masses are completely oblivious and will panic out of fear of the unknown, having no clue about the difference between ionizing vs. non-ionizing radiation, for example. Most of the population doesn’t even know the difference between an atomic element and a molecule. The government’s use of full-body hazmat suits will only exacerbate the fear, causing people to freak out over the apparent severity of the government’s response. No doubt the tyrannical government regime will exploit this fear to seize even more power. Informed readers have probably already realized that it is in the interests of the corrupt FBI, DOJ, DHS and other traitorous government entities to allow a dirty bomb attack to take place. These agencies benefit when they can “keep the fear alive,” and nothing spreads fear like a radiation bomb of some sort. Think 9/11 but instead of the twin towers and Building 7 being brought down via controlled demolition imagine five US cities being simultaneously contaminated with dirty bomb radiation. https://www.naturalnews.com/2022-05-18-cobalt-dirty-bombs-mrna-vaccine-suppression-chromosomes-cancer-death-wave.html ……………................….

Inside the Biden administration

Jacob Jeremiah Sullivan, NSA to Biden

Sullivan with Israel's National Security Adviser Meir Ben-Shabbat and Israel's Ambassador Gilad Erdan in April 2021 On November 22, 2020 Sullivan was announced as President-elect Joe Biden's choice to be National Security Advisor.[31] Upon his appointment Sullivan stated that the early priorities of Biden's National Security Council (NSC) are the COVID-19 pandemic, "restructuring the NSC to make public health a permanent national security priority", and China relations.[3] https://en.wikipedia.org/wiki/Jake_Sullivan#cite_note-31 ……….. Jewish Telegraphic Agency Michigan All the Jews Joe Biden has Tapped for Top Roles in His Administration By Jewish Telegraphic Agency 01/20/2021 (JTA) — President-elect Joe Biden filled the months before Inauguration Day lining up a slate of Cabinet secretaries, assistants and advisors, many of them Jewish. Biden’s choices reflect a diverse cross-section of American Jewry and possess expertise gleaned from decades of experience in government, science and medicine and law. Here’s a rundown of the Jewish names you should know as the Biden administration begins. Anthony Blinken, Secretary of State Blinken, a longtime Biden advisor with an extensive diplomacy resume, is the stepson of a Holocaust survivor whose stories shaped his worldview and subsequently his policy decisions, including in the Middle East. He holds mainstream Democratic views about Israel and said during his confirmation hearing Tuesday that he wants the U.S. to reenter the Iran nuclear deal — and that he would consult with Israel on Iran policy. David Cohen, CIA Deputy Director Cohen, who has long been involved in Jewish causes and issues, will occupy the job he held under President Barack Obama. He does not require confirmation, meaning that Biden’s CIA has a top expert in Iran issues from Day One. Merrick Garland, Attorney General Garland was blocked from joining the Supreme Court in the last year of the Obama administration. Now he’ll require Senate confirmation to become the country’s top lawyer. In his speech after being nominated, he credited his grandparents, who fled anti-Semitism in Europe before coming to the U.S. Avril Haines, Director of National Intelligence Haines was deputy director of the CIA under Obama and Biden reportedly considered her to run that agency. Her mother was the Jewish painter Adrian Rappin (originally Rappaport), and her non-Jewish father once wrote in an account about a trip with Haines to Israel that the nominee identifies as Jewish. Ronald Klain, Chief of Staff Klain, a longtime Biden who was the president-elect’s first major appointment in November, was previously chief of staff to Biden in his vice president days and to Vice President Al Gore. He has maintained ties with his childhood synagogue in Indianapolis, where he famously learned multiple Torah portions for his bar mitzvah, and has spoken about his commitment to raising Jewish children. Eric Lander, Office of Science and Technology Policy director Lander, a leading geneticist, will require Senate confirmation after Biden elevated his position to the Cabinet level. After he was criticized for toasting James Watson, the scientist who is credited with discovering the shape of DNA and who also expressed racist and sexist views, Lander said he too had been the subject of anti-Semitic comments by Watson. Rachel Levine, deputy health secretary Levine, raised in a Conservative Jewish home in Massachusetts, is Pennsylvania’s health secretary. She is the first known transgender person to be nominated for a position that requires Senate confirmation. Alejandro Mayorkas, Secretary of Homeland Security Mayorkas, 60, the deputy secretary of Homeland Security under President Barack Obama, was born in Cuba to a Cuban Jewish father and Romanian Jewish mother who survived the Holocaust. He has worked closely with Jewish groups and spoken often about the specific threats facing American Jews. An array of Jewish groups sought a swift confirmation given the threat of extremist violence surrounding the presidential transition, but a Republican Senator who supported overturning the election results blocked that possibility on Tuesday. Anne Neuberger, National Security Agency cybersecurity director Anne Neuberger attended an Orthodox Jewish day school for girls in Brooklyn. National Security Agency An Orthodox Jew originally from Brooklyn and educated through college in Orthodox schools, Neuberger has worked at the NSA for more than a decade. She helped establish the U.S. Cyber Command and worked as chief risk officer where she led the agency’s election security efforts for the 2018 midterms. Wendy Sherman, deputy secretary of state Wendy Sherman was the top U.S. negotiator in the world powers’ nuclear talks with Iran. Eric Bridiers/U.S. Mission Geneva Sherman was the lead negotiator for the 2015 Iran nuclear deal and took the lead in advocating for the agreement with the Jewish and pro-Israel communities, later describing tensions with Israel and some American Jewish groups over the deal as “very, very painful.” She has also played a role in hewing the Democratic Party platform to traditional pro-Israel lines. Janet Yellen, Treasury secretary Yellen already made history as the first woman chair of the Federal Reserve, but now she has been appointed to be the first female Treasury secretary. The respected centrist was one of three Jews featured in a 2016 Trump attack ad that reflected longstanding anti-Semitic tropes. ………….

Dr. Fauci; Marg Singer, the population agenda

CNN KHN  —  In January — long before the first jabs of covid-19 vaccine were even available to most Americans — scientists working under Dr. Anthony Fauci at the National Institute of Allergy and Infectious Diseases were already thinking about potential booster shots. A month later, they organized an international group of epidemiologists, virologists and biostatisticians to track and sequence covid variants. They called the elite group SAVE, or SARS-Cov-2 Variant Testing Pipeline. And by the end of March, the scientists at NIAID were experimenting with monkeys and reviewing early data from humans showing that booster shots provided a rapid increase in protective antibodies — even against dangerous variants. Fauci, whose team has closely tracked research from Israel, the United Kingdom and elsewhere, said in an exclusive interview with KHN on Wednesday that “there’s very little doubt that the boosters will be beneficial.” But, he emphasized, the official process, which includes reviews by scientists at the Food and Drug Administration and the Centers for Disease Control and Prevention, needs to take place first. “If they say, ‘We don’t think there’s enough data to do a booster,’ then so be it,” Fauci said. “I think that would be a mistake to be honest with you.” The support for an extra dose of covid vaccine clearly emerged, at least in part, from an NIH research dynamo built by Fauci that for months has been getting intricate real-time data about covid variants and how they respond to vaccine-produced immunity. The FDA and CDC were seeing much of the same data, but as regulatory agencies they were more cautious. The FDA in particular won’t rule on a product until the company making it submits extensive data. And its officials are gimlet-eyed reviewers of such studies. On boosters Americans have heard conflicting messages from various parts of the U.S. government. Yet Fauci said “there is less disagreement and conflicts than seem to get out into the tweetosphere.” He ticked off a number of prominent scientists in the field — including Surgeon General Vivek Murthy, acting FDA Commissioner Janet Woodcock and covid vaccine inventor Barney Graham — who were on board with his position. All but Graham are members of the White House covid task force. Another task force member, CDC Director Rochelle Walensky, said her agency was tracking vaccine effectiveness and “we’re starting to see some waning in terms of infections that foreshadows what we may be seeing soon in regard to hospitalizations and severe disease.” As to when so-called boosters should start, she told PBS NewsHour on Tuesday, “I’m not going to get ahead of the FDA’s process.” Expect a bumpy ride this week when FDA advisers consider Covid-19 booster shots Differences in the scientific community are likely to be voiced Friday when the FDA’s vaccine advisory board meets to review Pfizer-BioNTech’s request for approval of a third shot. Indeed, even the FDA’s official briefing paper before the meeting expressed skepticism. “Overall,” agency officials noted, “data indicate that currently US-licensed or authorized COVID-19 vaccines still afford protection against severe COVID-19 disease and death.” The agency also stated that it’s unclear whether an additional shot might increase the risk of myocarditis, which has been reported, particularly in young men, following the second Pfizer and Moderna shots. Part of the disagreement arose because President Joe Biden had announced that Americans could get a booster as soon as Sept. 20, a date Fauci and colleagues had suggested to him as practical and optimal in one of their frequent meetings just days before — though he cautioned that boosters would need CDC and FDA approval. Now it appears that that decision and the timing rest with the FDA, which is the normal procedure for new uses of vaccines or drugs. And Fauci said he respects that process — but he thinks it should come as quickly as possible. “If you’re doing it because you want to prevent people from getting sick, then the sooner you do it the better,” Fauci said. Researchers at the NIH typically focus on early-stage drug development, asking how a virus infects and testing ways to treat the infection. The job of reviewing and approving a drug or vaccine for public use is “just not how the NIH was set up. NIH does relatively little research on actual products,” said Diana Zuckerman, a former senior adviser to Hillary Clinton and president of the nonprofit National Center for Health Research in Washington, D.C. “It’s no secret that FDA doesn’t have the disease experts in the way that the NIH does,” Zuckerman said. “And it’s no secret that the NIH doesn’t have the experts in analyzing industry data.” Yet no other infectious disease expert in any branch of the U.S. government has Fauci’s influence. And while other scientific leaders support boosters, many scientists believe Fauci and his colleagues at the NIAID — some of the world’s leaders in immunology and vaccinology, men and women in daily contact with their foreign peers and their research findings — are leading the charge. Fauci was hard-pressed to give exact dates for when his thinking turned on the need for boosters. The past 18 months are a blur, he said. But “there’s very little doubt that the boosters will be beneficial. The Israelis already have that data in spades. They boost, they get an increase by tenfold in the protection against infection and severe disease.” In July Israel, which started vaccinating its population early and used only the Pfizer-BioNTech vaccine, began reporting severe breakthrough cases in previously vaccinated elderly people. Israel’s Ministry of Health announced boosters July 29. Fauci noted that Israel and — to a lesser extent — the U.K. were about a month and a half ahead of the U.S. at every stage of dealing with covid. And once Israel had boosted its population the Israeli scientists showed their NIH counterparts, hospitalizations of previously vaccinated people, which had been rising, dropped dramatically. Emerging evidence suggests boosters make people far less likely to transmit the virus to others, an important added benefit. To be sure members of the White House covid response team — including Fauci and former FDA Commissioner David Kessler — had begun preparing a timeline for boosters months earlier. Kessler, speaking to Congress in May, said that it was unclear then whether the boosters would be needed but that the U.S. had the money to purchase them and ensure they were free. Fauci explained that “practically speaking the earliest we could do it would be the third week in September. Hence the date of the week of September the 20th was chosen.” The hope was that would give regulators enough time. The FDA’s advisory board meeting Friday is set to be followed next week by a gathering of the CDC’s immunization advisory committee, which offers recommendations for vaccine use that can lead to legal mandates. Tuesday Dr. Sharon Alroy-Preis, Israel’s head of public health services, told a Hebrew-language webinar that her country’s booster launch came at a critical time. She provided supporting data that Israeli scientists are bringing to the FDA meeting Friday. Some U.S. scientists have discussed limiting the boosters mostly to those over 60, Alroy-Preis noted, but “if you don’t keep it under control, it’s like a pot on the flame. If you don’t start lowering the flames of the pandemic, you can’t control it.” Scientists tracking the coronavirus are swimming in data. Hundreds of covid studies are published or released onto pre-publication servers every day. Scientists also share their findings on group email lists and in Zoom meetings every week — and on Twitter and in news interviews. Kessler, chief science officer of the White House covid response team, said the case for boosters is “rooted in NIH science” but includes data from Israel, the Mayo Clinic, the pharmaceutical companies and elsewhere. As Fauci put it: “Every 15 minutes a pre-print server comes out with something I don’t know.” The SAVE group, active since February, was organized by NIH officials who in normal times track influenza epidemics. The 60 to 70 scientists are mostly from U.S. agencies such as the NIH, CDC, FDA and Biomedical Advanced Research and Development Authority but also from other countries, including Israel and the Netherlands. “This is very much the basic scientists who are in the weeds trying to figure things out,” said Dr. Daniel Douek, chief of the human immunology section within NIAID. Douek said the larger SAVE group meets every Friday but several subgroups meet several times a week, focusing on different aspects of the virus, such as early detection of viral variants and testing suspicious variants for their ability to evade vaccine-induced immunity and sicken vaccinated mice and monkeys. The sharing of data and information is free-flowing, Douek said. SAVE is “an amazing thing.” Dr. Robert Seder, an NIH senior investigator, was in a group testing the booster theory long before America’s Summer of Delta. The researchers injected rhesus macaque monkeys with the Moderna vaccine for the “express purpose of looking at immune responses over a long period of time.” “Are they durable? And would you need to boost?” Seder said. Matthew Frieman, a participant and associate professor of microbiology at the University of Maryland School of Medicine, said the data makes it clear that the time for boosters is approaching. Biden’s booster announcement “may have gotten ahead of the game, but the trajectory is pointing toward the need for boosters,” Frieman said. “The level of antibody you need to protect against delta is higher because it replicates faster.” While SAVE is an elite group, it’s not the only forum for discussing late-breaking data, said Natalie Dean, a biostatistician at the Rollins School of Public Health at Emory University. “We all saw the same data out of Israel,” she said. Dean, like many other scientists, found that data unconvincing. Monday, an international group of scientists led by Dr. Philip Krause, deputy chief of the FDA’s vaccine regulation office, and including his boss, Dr. Marion Gruber, published an essay in The Lancet that questioned the need for widespread booster shots at this time. Krause and Gruber had announced their retirements from the FDA on Aug. 30 — at least partly in response to the booster announcement, according to four scientists who know them. Gruber, who will remain at the agency until later this fall, is listed as a participant in Friday’s meeting. The Lancet paper argues that vaccine-based protection against severe covid is still strong, while evidence is lacking that booster shots will be safe and effective. University of Florida biostatistician Ira Longini, a co-author on the Lancet paper, said it would be “immoral” to begin widespread boosters before the rest of the world was better vaccinated. As the disease continues its global spread, he noted, it is likely to develop deadlier and more vaccine-evasive mutants. Longini was also skeptical of an August study, which Israeli scientists are to present to the FDA on Friday, that NIH officials had touted as strong evidence in support of boosters. On an Aug. 24 call with Israeli officials, Fauci urged them to publish that data, and a version appeared in the New England Journal of Medicine on Wednesday. That study found that people receiving a third dose of the Pfizer-BioNTech vaccine were 11 times more likely to be protected from covid infection than those who had gotten only two doses. But the study observed people for less than two weeks after their booster vaccinations kicked in. Biostatisticians felt it had irregularities that raised questions about its worth. “I don’t want to say the study isn’t correct, but it hasn’t been reviewed and there are possible biases,” said Longini, who helped design the 2015 trial that resulted in a successful Ebola vaccine and now works on global covid vaccine trials. Fauci emphasized that no single study or piece of data led Biden or the members of the White House covid response team to conclude that boosting was necessary. The compilation of evidence of waning immunity combined with reams of research was a factor. Now the crucial decisions are in the hands of the regulators, awaiting the FDA and CDC’s judgment on how the nation should proceed. “It isn’t as if,” Fauci said, “one day we’re sitting in the Oval Office saying, ‘You know, Mr. President, I think we need to boost.’ And he says, ‘Tony, go ahead and do it.’ You can’t do it that way. You’ve got to go through the process.” https://www.cnn.com/2021/09/16/health/covid-19-boosters-agencies-khn-partner/index.html …………..............................

The United Nations has published its goal of reducing the world's population: a Original Title: Global 2000 Report for Pres Carter the Population Control Agenda Uploaded by Guy Razer The Population Reduction Agenda aka How To Get Rid Of 90% Of The World Population Designated As USELESS EATERS By Kissinger!   The Population Control Agenda Stanley K. Monteith, M.D. It was not until I journeyed to Elberton, Georgia, stood within the dark shadows of the great Druid-like monument built there, and read the words engraved on the massive stone pillars of that structure that I finally came to accept the truth. At that point it became obvious that just as our Lord has given mankind Ten Commandments to guide our lives, so too those from "the dark side" have been given their instructions from the "one" they worship. The ten programs of the "guides" are inscribed in eight different languages onthe four great granite pillars of the American Stonehenge. That message foretells aterrifying future for humanity, and explains why efforts to approach the AIDS epidemicfrom a logical point of view have been consistently thwarted. One of the most difficult concepts for Americans to accept is that there are human beings dedicated to coercive population control and genocide. Many readers will acknowledgethat our government is helping to finance the Red Chinese program of forced abortion, forced sterilization, infanticide and control of the numbers of live births. Most readerswill accept the fact that our nation is helping to finance the United Nations' world-wide"family planning program," a form of population control. Most rational men and women, however, find it impossible to believe that such programs are really part of a "master  plan" to kill off large segments of the world's population. I shall have to admit that I studied the politics of AIDS (HIV disease) for over a decade before I finally came to ahorrifying conclusion. The real motivation behind efforts to block utilization of standard public health measures to control further spread of the HIV epidemic was "populationcontrol." That was not an easy concept for me to acknowledge, despite the fact that I hadlong recognized that the twentieth century has been the bloodiest hundred-year period in all recorded human history. …On the other hand should you determine that my assessment is correct, or even partially correct, then you have a moral obligation to decide just what part you intend to play in response to the unfolding world genocide - how you will protect yourself, your loved ones, and the countless millions of helpless human beings throughout the world who have been marked for destruction…..The question that I am most frequently asked is, "How can you possibly believe that there are people who intend to kill off large segments of the world's population?" My answer isreally quite simple. I hold that belief because I have read their writings. I believe they aretelling the truth. Just as Adolf Hitler wrote of his plans for Europe in "Mein Kampf" (MyPlan), so, too, those who intend to depopulate large segments of the Earth have written of the necessity of limiting the world's population. They fully intend to "exterminate" asignificant portion of the world's population. The fact that the vast majority of Americans have never heard of their intent, of The Georgia Guidestones in Elberton, or of "ThePlan" and "The Hierarchy" attests to the degree of control that exists over what the American people have been allowed to know about the Occultic forces which areworking within our society today.Margaret Sanger and Planned ParenthoodAs you read on you will soon discover that I have primarily relied on material which can be readily found in books, audio-taped interviews, and public news sources. If you takethe time to check my references, you will soon discover that there really are those whohave publicly advocated the elimination of "human weeds" and "the cleansing of society."Indeed, to this very day your tax money is used to finance Planned Parenthood, an organization founded by Margaret Sanger. During the 1930s Margaret Sanger openly supported the Nazi plan for genetic engineering of the German population, and the propagation of a "super race." In Planned Parenthood's 1985 "Annual Report" leaders of that organization proclaimed that they were, "Proud of our past, and planning for our future."  How could anyone possibly claim to be proud of the organization founded by Margaret Sanger when history records that she wrote of the necessity of: "the extermination of 'human weeds' ...the 'cessation of charity,' ... the segregation of 'morons, misfits, and the maladjusted,' and ... the sterilization of 'genetically inferior races."4 Margaret Sanger published "The Birth Control Review." In that magazine she openly supported the "infanticide program" promoted by Nazi Germany in the 1930s, and publicly championed Adolf Hitler's goal of Aryan white supremacy. In the years prior toWorld War II Margaret Sanger commissioned Ernst Rudin, a member of the Nazi Party,and director of the dreaded German Medical Experimentation Programs, to serve as anadvisor to her organization. In his excellent book "Killer Angel," George Grant chronicles the life and writings of Margaret Sanger, and painstakingly documents Sanger's plans for the genetic engineering of the human race. George Grant noted that in the 1920s MargaretSanger wrote "The Pivot of Civilization" in which she called for: "The 'elimination of 'human weeds,' for the 'cessation of charity' because it prolonged the lives of the unfit, for the segregation of 'morons, misfits, and the maladjusted,' and for the sterilization of genetically inferior races."5 According to George Grant, Margaret Sanger believed that the unfit should not be allowed to reproduce. Accordingly, she opened a birth control clinic in: "The Brownsville section of New York, an area populated by newly immigrated Slavs, Latin's, Italians, and Jews. She targeted the 'unfit' for her crusade to 'save the planet.6 Nineteen years later, in 1939, Margaret Sanger organized her "Negro project," a program designed to eliminate members of what she believed to be an "inferior race."Margaret Sanger justified her proposal because she believed that: "The masses of  Negroes ...particularly in the South, still breed carelessly and disastrously, with the resultthat the increase among Negroes, even more than among whites, is from that portion of the population least intelligent and fit..."7 Margaret Sanger then went on to reveal that she intended to hire three or four Colored Ministers "to travel to various black enclaves to propagandize for birth control." She wrote: "The most successful educational approach to the Negro is through a religious appeal. We do not want word to go out that we want to exterminate the Negro population, and the Minister is the man who can straighten out that idea if it ever occurs to any of their more rebellious members." (emphasis added-Ed.)8 As Margaret Sanger's organization grew in power, influence, and acceptance, she began to write of the necessity of targeting religious groups for destruction as well, believingthat the "dysgenic races" should include "Fundamentalists and Catholics" in addition to"blacks, Hispanics, (and) American Indians."9 As the years went by, Margaret Sanger became increasingly obsessed with her Occultic beliefs. Along with her acceptance of the occult, she became increasingly hostile to both Christianity and the American precepts of individual freedom under God. Her distaste for America can be seen in her writings when she wrote: "Birth control appeals…” http://www.scribd.com/doc/8533561/Global-2000-Report-for-Pres-Carter-the-Population-Control-Agenda ……………............................ September 22, 2021 Tiasangla Longkumer (PhD, Jawaharlal Nehru University; ICS-HYI Fellow) Abstract: Margaret Sanger’s Euro-American eugenic discourse in birth control have exerted a prominent role in propagandizing the issue of birth control in public debates and discussions in India and China. Positioned at the nexus of a complex web of national and international initiatives, this essay traces the history of Margaret Sanger’s birth control movement in Colonial India and Republican China in the 1920s and 1930s. Modeled within the ideological framework of Neo-Malthusianism that located birth control in the concerns of ‘overpopulation, disease and poverty,’ this essay attempts to examine the introduction of Sanger’s eugenic concerns and its influence on both the Indian and Chinese intellectuals of the time and how these ideas came to be seen as a modern, rational, progressive science, whose utopic potentials could save both the countries from its growing population with limited resources. Sanger was also able to garner support for her birth control project from one of the most wealthy and prominent family, the Rockefeller’s since the early years of her birth control advocacy. Committed to the idea of birth control and enhanced control over family size and composition, Rockefeller displayed sustained commitments to Sanger’s birth control project. Rockefeller involvement in the population project since the birth of the eugenic movement was seen as a powerful and influential factor in the advancement of the population control agenda. Support from powerful philanthropist like the Rockefeller’s played a prominent role in furthering Sanger’s birth control agenda on a global scale. https://www.harvard-yenching.org/research/the-rockefellers-margaret-sanger-and-the-eugenic-dimension-of-birth-control-in-colonial-india-and-republican-china/ .

How Jews Changed the World

Özlem Türeci, Co-Founder and Chief Medical Officer  By David Gelles • Nov. 10, 2020 Leer en españolLire en français Two years ago, Dr. Ugur Sahin took the stage at a conference in Berlin and made a bold prediction. Speaking to a roomful of infectious disease experts, he said his company might be able to use its so-called messenger RNA technology to rapidly develop a vaccine in the event of a global pandemic. At the time, Dr. Sahin and his company, BioNTech, were little known outside the small world of European biotechnology start-ups. BioNTech, which Dr. Sahin founded with his wife, Dr. Özlem Türeci, was mostly focused on cancer treatments. It had never brought a product to market. Covid-19 did not yet exist. But his words proved prophetic. On Monday, BioNTech and Pfizer announced that a vaccine for the coronavirus developed by Dr. Sahin and his team was more than 90 percent effective in preventing the disease among trial volunteers who had no evidence of having previously been infected. The stunning results vaulted BioNTech and Pfizer to the front of the race to find a cure for a disease that has killed more than 1.2 million people worldwide. “It could be the beginning of the end of the Covid era,” Dr. Sahin said in an interview on Tuesday. BioNTech began work on the vaccine in January, after Dr. Sahin read an article in the medical journal The Lancet that left him convinced that the coronavirus, at the time spreading quickly in parts of China, would explode into a full-blown pandemic. Scientists at the company, based in Mainz, Germany, canceled vacations and set to work on what they called Project Lightspeed. “There are not too many companies on the planet which have the capacity and the competence to do it so fast as we can do it,” Dr. Sahin said in an interview last month. “So it felt not like an opportunity, but a duty to do it because I realized we could be among the first coming up with a vaccine.” After BioNTech had identified several promising vaccine candidates, Dr. Sahin concluded that the company would need help to rapidly test them, win approval from regulators and bring the best candidate to market. BioNTech and Pfizer had been working together on a flu vaccine since 2018, and in March they agreed to collaborate on a coronavirus vaccine. Since then Dr. Sahin, who is Turkish, has developed a friendship with Albert Bourla, the Greek chief executive of Pfizer. The pair said in recent interviews that they had bonded over their shared backgrounds as scientists and immigrants. “We realized that he is from Greece and that I’m from Turkey,” Dr. Sahin said, without mentioning their native countries’ long-running antagonism. “It was very personal from the very beginning.”  Dr. Sahin, 55, was born in Iskenderun, Turkey. When he was 4 his family moved to Cologne, Germany where his parents worked at a Ford factory. He grew up wanting to be a doctor and became a physician at the University of Cologne. In 1993 he earned a doctorate from the university for his work on immunotherapy in tumor cells. Early in his career he met Dr. Türeci. She had early hopes to become a nun and ultimately wound up studying medicine. Dr. Türeci, now 53 and the chief medical officer of BioNTech, was born in Germany, the daughter of a Turkish physician who immigrated from Istanbul. On the day they were married, Dr. Sahin and Dr. Türeci returned to the lab after the ceremony. The pair were initially focused on research and teaching, including at the University of Zurich where Dr. Sahin worked in the lab of Rolf Zinkernagel, who won the 1996 Nobel Prize in medicine. In 2001 Dr. Sahin and Dr. Türeci founded Ganymed Pharmaceuticals which developed drugs to treat cancer using monoclonal antibodies. After several years they founded BioNTech as well, looking to use a wider range of technologies including messenger RNA to treat cancer. “We want to build a large European pharmaceutical company,” Dr. Sahin said in an interview with the Wiesbaden Courier, a local paper. Even before the pandemic, BioNTech was gaining momentum. The company raised hundreds of millions of dollars and now has more than 1,800 people on staff, with offices in Berlin, other German cities and Cambridge, Mass. In 2018 it began its partnership with Pfizer. Last year the Bill & Melinda Gates Foundation invested $55 million to fund its work treating H.I.V. and tuberculosis. Also in 2019 Dr. Sahin was awarded the Mustafa Prize, a biennial Iranian prize for Muslims in science and technology.  Dr. Sahin and Dr. Türeci sold Ganymed for $1.4 billion in 2016. Last year, BioNTech sold shares to the public; in recent months its market value has soared past $21 billion, making the couple among the richest in Germany. The two billionaires live with their teenage daughter in a modest apartment near their office. They ride bicycles to work. They do not own a car. “Ugur is a very, very unique individual,” Mr. Bourla, Pfizer’s chief executive, said in the interview last month. “He cares only about science. Discussing business is not his cup of tea. He doesn’t like it at all. He’s a scientist and a man of principles. I trust him 100 percent.”  In Germany where immigration continues to be a fractious issue the success of two scientists of Turkish descent was cause for celebration. “With this couple Germany has a shining example of successful integration,” wrote the conservative-business site Focus. A member of Parliament, Johannes Vogel, wrote on Twitter that if it was up to the far-right Alternative for Germany party, “there would be no #BioNTech of Germany with Özlem Türeci & Ugur Sahin at the top.” “If it were up to critics of capitalism and globalization,” he added, “there would be no cooperation with Pfizer. But that makes us strong: immigration country, market economy & open society!” Dr. Sahin has had little time for politics this year. BioNTech has been so busy developing a vaccine that the company has not finalized the financial details of its partnership agreement with Pfizer. “Trust and personal relationship is so important in such business because everything is going so fast,” Dr. Sahin said. “We still have a term sheet and not yet a final contract on many things.” Dr. Sahin said he and Dr. Türeci learned about efficacy data on Sunday night and marked the moment by brewing Turkish tea at home. “We celebrated, of course,” he said. “It was a relief.” Christopher F. Schuetze contributed reporting from Berlin. David Gelles is the Corner Office columnist and a business reporter, Twitter. @dgelles https://www.nytimes.com/2020/11/10/business/biontech-covid-vaccine.html ……….. About Ozlem Tureci, Scientist, immunologist and cancer researcher Ozlem Tureci is the cofounder and chief medical officer of BioNTech, a German biotech firm. • In 2020 with Pfizer, BioNTech developed the first mRNA Covid vaccine to be approved for mass use. Tureci led the clinical development of the research, which BioNTech called Project Lightspeed. • Before cofounding BioNTech with her husband, Ugur Sahin, Tureci served as CEO and Chief Medical Officer for Ganymed Pharmaceuticals, which she also co-founded with Sahin and Christoph Huber. Tureci also serves as president of the Association for Cancer Immunotherapy (CIMT) in GermanyBorn in West Germany to Turkish immigrant parents, Tureci was destined for a career in science and healthcare: her mom was a biologist and her father was a surgeon. https://www.forbes.com/profile/ozlem-tureci/?sh=5b036b525493 …………………. Let’s begin with the vaccine. On Friday, November 13, Prime Minister Benjamin Netanyahu signed a deal with the giant US pharmaceutical company Pfizer to purchase millions of coronavirus vaccine doses. It was only days after Pfizer announced clinical trials showed the vaccine was 90% effective at preventing COVID-19. Later reports raised its effectiveness to 95%. Pfizer’s CEO is Albert Bourla. Bourla is Jewish. He was born, raised and educated in Thessaloniki, in northern Greece. He left Greece with his wife when he was 34. In early 2020, Bourla pushed to accelerate Pfizer’s development of a possible vaccine against COVID-19. He did this in partnership with the German company BioNTech, founded by a Turkish-born married couple, Dr. Ugur Sahin, 55, and Dr. Ozlem Tureci, 53, who were educated in Germany, where they now live and work. Bourla boldly ordered preparations for production to begin, well before approval from the US Food and Drug Administration. Dr. Noubar Afeyan, 58, is co-founder and chairman of the biotech company Moderna. Afeyan is Armenian, emigrated from Lebanon to Canada and eventually did his doctorate at MIT. His company Moderna was born in the famous MIT lab of Prof. Robert Langer. • Moderna’s chief medical officer is Dr. Tal Zaks, an Israeli who completed his M.D. degree at Ben-Gurion University of the Negev. Like the Pfizer-BioNTech version, Moderna’s COVID-19 vaccine too has proven highly effective in clinical trials. Dr. Zaks believes the initial doses will arrive in Israel in early 2021. https://www.jpost.com/jerusalem-report/how-jews-change-the-world-652199 …………. • NewsLocal After COVID, Cancer Vaccine on Horizon With vaccinations in full swing gene therapy for cancer may only be few years away. By Bob Bahr April 29, 2021 The gene science that led to the coronavirus vaccine has the potential to treat many diseases in the future. Scientists who helped develop the Pfizer COVID-19 vaccine predict that same technology may be used to develop a vaccine for cancer. Dr. Ozlem Tureci who, with her husband runs the German research firm BioNTech that created the Pfizer vaccine, originally set up the company 13 years ago to develop new treatments for cancer. She told The Times of Israel last month that the firm now has “several different cancer vaccines” that are under development. “We expect that within only a couple of years, we will also have our vaccines [against] cancer at a place where we can offer them to people.” Both the COVID-19 vaccine and the new experimental cancer vaccines are based on technology that uses genetic matter known as messenger ribonucleic acid (mRNA). The inoculations use gene therapy to deliver genetic instructions to individual cells in the body that can be manipulated to reflect newly emerging challenges to health. Emory University has started testing a reformulation of the Moderna vaccine that guards against COVID variants. These individual cells, in turn, develop proteins that create antibodies to act against dangerous viruses. Scientists at Emory Vaccine Center, for example, have begun testing a new formulation of the Moderna vaccine that is hoped can be more effective against the recent variants of the COVID-19 virus. The same mRNA technology can be used, in the case of cancer, to actually fight the malignancy. Dr. Mark Borodovsky of Georgia Tech has been an international leader in genetic research. Mark Borodovsky, a Georgia Tech biomechanical engineering professor, said this is a quick and easy way to stop disease. “The immune system is trained to create antibodies that, in case of a viral infection, guide the immune system and kill the virus.” The University of Texas MD Anderson Center scientists have already used mRNA based treatments to prevent the reoccurrence of cancer, which is said to be particularly the case in ovaries, the bladder and the brain. A reoccurrence of the disease takes place when cancer cells are not completely killed off by chemotherapy or radiation. In a clinical trial now in its second stage, researchers at the Anderson Center have developed mRNA vaccines individually tailored to each patient. The goal is to destroy the cancer cells still present in the body and permanently head off the disease. In his new book “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of The Human Race,” Walter Isaacson describes these advances. Isaacson, who once served as president of CNN in Atlanta, spoke last month at the Book Festival of the MJCCA. Walter Isaacson’s new book was discussed in a program at the Book Festival of the MJCCA He describes in his book the speed of recent advances. It took only two days, for example, for Moderna to create the proper mRNA sequence that would be used in the new inoculation, and only 38 days before the first box of vials was shipped off to the National Institutes of Health to begin the first clinical trials. In earlier times vaccines that used other techniques often took years of trial and error before a proper immune response could be developed. In the case of the recent vaccine, Isaacson said it’s just a matter of unlocking the genetic code of the cell and a flood of new therapies could be developed. “These genetic improvements,” he says, “could permanently alter the human race.” The leaders in many of these efforts have often been Jewish scientists. The chairman and CEO of the international pharmaceutical giant Pfizer is Albert Bourla, the son of Greek Holocaust survivors. Tal Zaks, a native of Israel, is chief medical officer of Moderna, which developed the other vaccine widely in use in this country. Zaks has been working for years on using mRNA in an attempt to develop treatments for life threatening disease that could be personalized for each patient, so it was a quick pivot to focus on how an mRNA vaccine could be tailored to produce antibodies against the coronovirus. Borodovsky, who first came to Atlanta in the first wave of Jewish immigration from the Soviet Union in 1990, has been at the forefront of this rapidly developing frontier of modern medicine. As the founder and director of the Center for Bioinformatics and Computational Genomics at Georgia Tech, he has been instrumental in developing new ways of sequencing the genome, the key to the foundational building blocks of all human life. His work has been supported by The Marcus Foundation, funded by the cofounder of Home Depot Bernie Marcus. In 2006 Marcus gave the university $15 million to build a research center to explore what are called nano particles, the small building blocks of all matter. He also established the Marcus Center for Therapeutic Cell Characterization and Manufacturing to develop new medical initiatives in the pharmaceutical and biotechnology industries. According to Dr. Borodovsky, recent medical advances and the COVID vaccines are simply technology urged on by the world’s medical needs, catching up with basic science. “It can take 30 years to come up with a concept and get this concept up to realization in a technological sense. So now we talk about several months.” https://www.atlantajewishtimes.com/after-covid-cancer-vaccine-on-horizon/ ………….. NewsLocal • After COVID, Cancer Vaccine on Horizon With vaccinations in full swing, gene therapy for cancer may only be few years away. By Bob Bahr April 29, 2021 The gene science that led to the coronavirus vaccine has the potential to treat many diseases in the future. • Scientists who helped develop the Pfizer COVID-19 vaccine predict that same technology may be used to develop a vaccine for cancer. • Dr. Ozlem Tureci who, with her husband runs the German research firm BioNTech that created the Pfizer vaccine, originally set up the company 13 years ago to develop new treatments for cancer. She told The Times of Israel last month that the firm now has “several different cancer vaccines” that are under development. “We expect that within only a couple of years, we will also have our vaccines [against] cancer at a place where we can offer them to people.” Both the COVID-19 vaccine and the new experimental cancer vaccines are based on technology that uses genetic matter known as messenger ribonucleic acid (mRNA). The inoculations use gene therapy to deliver genetic instructions to individual cells in the body that can be manipulated to reflect newly emerging challenges to health. Emory University has started testing a reformulation of the Moderna vaccine that guards against COVID variants. These individual cells, in turn, develop proteins that create antibodies to act against dangerous viruses. • Scientists at Emory Vaccine Center, for example, have begun testing a new formulation of the Moderna vaccine that is hoped can be more effective against the recent variants of the COVID-19 virus. The same mRNA technology can be used, in the case of cancer, to actually fight the malignancy. Dr. Mark Borodovsky of GeorgiaTech has been an international leader in genetic research. Mark Borodovsky, a Georgia Tech biomechanical engineering professor, said this is a quick and easy way to stop disease. “The immune system is trained to create antibodies that, in case of a viral infection, guide the immune system and kill the virus.” The University of Texas MD Anderson Center scientists have already used mRNA based treatments to prevent the reoccurrence of cancer, which is said to be particularly the case in ovaries, the bladder and the brain. A reoccurrence of the disease takes place when cancer cells are not completely killed off by chemotherapy or radiation. In a clinical trial now in its second stage, researchers at the Anderson Center have developed mRNA vaccines individually tailored to each patient. The goal is to destroy the cancer cells still present in the body and permanently head off the disease. In his new book “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of The Human Race,” Walter Isaacson describes these advances. Isaacson, who once served as president of CNN in Atlanta, spoke last month at the Book Festival of the MJCCA. Walter Isaacson’s new book was discussed in a program at the Book Festival of the MJCCA • He describes in his book the speed of recent advances. It took only two days, for example, for Moderna to create the proper mRNA sequence that would be used in the new inoculation, and only 38 days before the first box of vials was shipped off to the National Institutes of Health to begin the first clinical trials. In earlier times, vaccines that used other techniques often took years of trial and error before a proper immune response could be developed. In the case of the recent vaccine, Isaacson said it’s just a matter of unlocking the genetic code of the cell and a flood of new therapies could be developed. “These genetic improvements,” he says, “could permanently alter the human race.” The leaders in many of these efforts have often been Jewish scientists. The chairman and CEO of the international pharmaceutical giant Pfizer is Albert Bourla, the son of Greek Holocaust survivors. Tal Zaks, a native of Israel, is chief medical officer of Moderna, which developed the other vaccine widely in use in this country. Zaks has been working for years on using mRNA in an attempt to develop treatments for life threatening disease that could be personalized for each patient, so it was a quick pivot to focus on how an mRNA vaccine could be tailored to produce antibodies against the coronovirus. Borodovsky, who first came to Atlanta in the first wave of Jewish immigration from the Soviet Union in 1990, has been at the forefront of this rapidly developing frontier of modern medicine. As the founder and director of the Center for Bioinformatics and Computational Genomics at Georgia Tech, he has been instrumental in developing new ways of sequencing the genome, the key to the foundational building blocks of all human life. His work has been supported by The Marcus Foundation, funded by the cofounder of Home Depot Bernie Marcus. In 2006 Marcus gave the university $15 million to build a research center to explore what are called nano particles, the small building blocks of all matter. He also established the Marcus Center for Therapeutic Cell Characterization and Manufacturing to develop new medical initiatives in the pharmaceutical and biotechnology industries. According to Dr. Borodovsky, recent medical advances and the COVID vaccines are simply technology urged on by the world’s medical needs, catching up with basic science. “It can take 30 years to come up with a concept and get this concept up to realization in a technological sense. So now we talk about several months.” https://www.atlantajewishtimes.com/after-covid-cancer-vaccine-on-horizon/ …………. In his new book “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of The Human Race,” Walter Isaacson describes these advances. Isaacson, who once served as president of CNN in Atlanta, spoke last month at the Book Festival of the MJCCA. Walter Isaacson’s new book was discussed in a program at the Book Festival of the MJCCA He describes in his book the speed of recent advances. It took only two days, for example, for Moderna to create the proper mRNA sequence that would be used in the new inoculation, and only 38 days before the first box of vials was shipped off to the National Institutes of Health to begin the first clinical trials. In earlier times, vaccines that used other techniques often took years of trial and error before a proper immune response could be developed. In the case of the recent vaccine, Isaacson said it’s just a matter of unlocking the genetic code of the cell and a flood of new therapies could be developed. “These genetic improvements,” he says, “could permanently alter the human race.” • The leaders in many of these efforts have often been Jewish scientists. The chairman and CEO of the international pharmaceutical giant Pfizer is Albert Bourla, the son of Greek Holocaust survivors. Tal Zaks, a native of Israel, is chief medical officer of Moderna, which developed the other vaccine widely in use in this country. • Zaks has been working for years on using mRNA in an attempt to develop treatments for life threatening disease that could be personalized for each patient, so it was a quick pivot to focus on how an mRNA vaccine could be tailored to produce antibodies against the coronovirus. Borodovsky, who first came to Atlanta in the first wave of Jewish immigration from the Soviet Union in 1990, has been at the forefront of this rapidly developing frontier of modern medicine. As the founder and director of the Center for Bioinformatics and Computational Genomics at Georgia Tech, he has been instrumental in developing new ways of sequencing the genome, the key to the foundational building blocks of all human life. His work has been supported by The Marcus Foundation, funded by the cofounder of Home Depot Bernie Marcus. In 2006 Marcus gave the university $15 million to build a research center to explore what are called nano particles, the small building blocks of all matter. He also established the Marcus Center for Therapeutic Cell Characterization and Manufacturing to develop new medical initiatives in the pharmaceutical and biotechnology industries. According to Dr. Borodovsky, recent medical advances and the COVID vaccines are simply technology urged on by the world’s medical needs, catching up with basic science. “It can take 30 years to come up with a concept and get this concept up to realization in a technological sense. So now we talk about several months.” 12-22-2020 How Jews change the world - The Jerusalem Post https://www.jpost.com › Opinion ……………….......................

the sudden/hasty step-up in gain-of-function r and d

February 26, 2023 - S.D. Wells From LAB to LUNGS: The real COVID timeline in a nutshell (Natural News) . Here’s where it all began, and how we got to where we are today. December, 2004: Liver damage from SARS vaccine documented. Lab animals (ferrets) vaccinated with rMVA-S and then exposed to SARS-CoV suffered liver damage from elevated levels of a specific enzyme, as discovered by researchers in Canada 16 years before the Wuhan virus was released from labs in China. Canadian researchers were developing a vaccine for SARS and started testing it on ferrets in laboratories, as reported in the Journal of Virology, when they found hepatitis in the ferrets and began urging extreme caution for other investigators working on SARS vaccines. Virus Mania: How the Medical Industry Continually Invents Epidemics, Making Billion-Dollar Profits At Our Expense Paperback – September 19, 2007 by Torsten Engelbrecht (Author), Claus Köhnlein (Contributor) A daily scan through the news gives the impression that the world is constantly invaded by virus epidemics. The latest headlines feature the human papillomavirus (HPV) alleged to cause cervical cancer and the avian flu virus, H5N1. The public is also continually terrorized by reports about SARS, BSE, hepatitis C, AIDS, Ebola and polio. However, this virus mayhem ignores very basic scientific facts: the existence, the pathogenicity and deadly effects of these agents have never been proven. The authors of Virus Mania, journalist Torsten Engelbrecht and doctor of internal medicine Claus Köhnlein, show that these alleged contagious agents are, in fact, particles produced by the cells themselves as a consequence of certain stress factors such as drugs, malnutrition, pesticides and heavy metals. The central aim of this book is to steer the discussion back to a real scientific debate and put medicine back on the path of an impartial analysis of the facts. It will put medical experiments, clinical trials, statistics and government policies under the microscope, revealing that the people charged with protecting our health and safety have deviated from this path. To substantiate these statements the authors cite dozens of highly renowned scientists and present approximately 1,100 pertinent scientific references. The topic of this book is of pivotal significance. The pharmaceutical companies and top scientists rake in enormous sums of money by attacking germs and the media boosts its audience ratings and circulations with sensationalized reporting (the coverage of the New York Times and Der Spiegel are specifically analyzed). "The primary purpose of commercially-funded clinical research is to maximize financial return on investment, not health," says John Abramson of Harvard Medical School. Virus Mania will inform you on how such an environment took root-and how to empower yourself for a healthy life. https://www.amazon.com/Virus-Mania-Continually-Epidemics-Billion-Dollar/dp/1425114679 ………………… September 2010: The year was 2010, and Bill Gates said the quiet part out loud, at a TED conference, explaining how the world population could be reduced by several billion people if we … “do a really great job on new vaccines, healthcare, and reproductive services…” and by healthcare and reproductive services, he meant abortions, and by vaccines he meant instead of just causing extreme allergies, asthma, and autism, that NEW vaccines literally exterminate people, as the Covid clot shots do now by sending millions of spike proteins into vital organs, while clogging up the vascular system, causing turbo cancer and heart attacks. Bill Gates planned it all: How to depopulate the planet with abortions and “new vaccines” – listen to him speak on planned genocide at TED talks. November 2015: • Viruses that are related to SARS and that are found in some species of bats could become a source of future human outbreaks, ]according to a new study (some of which is shown below) released Monday. And it appears that there are fewer barriers to that spillover than scientists initially thought…. The UNC scientists wanted to see if cousin viruses — coronaviruses that are carried by Chinese horseshoe bats — also posed a threat to people. They used one, SHC014, as a representative of the group. They inserted a key part of the virus, its spike protein, into a SARS virus and then ran experiments to see if the hybrid virus could infect human respiratory tract cells (in a dish) and mice that were vulnerable to the SARS virus. It did. “I think the existence of viruses that can jump directly is the important part, that was unanticipated,” lead author Vineet Menachery, who researches viral immunology, told STAT in an interview. “Based on what was known in the literature, we would have expected that viruses coming out of bats would have needed that one-in-million mutation.” Another coronavirus expert, Dr. Stanley Perlman at the University of Iowa, suggested the paper was a useful investigation. But he noted the hybrid virus was attenuated — weakened — and said the virus would probably need to adapt more in people before it could spread widely. SARS wasn’t a highly transmissible virus. Many patients didn’t infect anyone else during the 2003 outbreak. Once hospitals learned how to recognize the disease and put stringent infection control measures in place — isolating patients and requiring staff treating them to wear the right protective equipment — the outbreak was contained. The SHC014 virus is part of a cluster of related coronaviruses, explained senior author Ralph Baric, a professor of epidemiology at UNC. Some are quite similar to the SARS virus while others are more distant relatives, varying in terms of their genetic structures by between 5 percent and 60 percent. SHC014 was about 12 percent different from SARS. A coronavirus expert, Baric said if the viruses were too distantly related to SARS — more than 25 percent different — they would not be able to make a hybrid that would infect human cells. “Not all SARS-like coronaviruses have the inherent potential to replicate in mammalian cells and replicate in human cells.” And being able to do something in the artificial confines of a laboratory does not guarantee it will happen in nature. For a bat virus to start infecting people, the bat would have to come into contact with people in a way that would allow transmission. Even if a single person became infected, the virus would have to work efficiently in human cells, producing lots of copies of itself that could be coughed or sneezed out toward the airways of other people. “There are a lot of steps down this road,” Menachery said. “SHC014 has taken a step ahead. But there’s still a lot of other factors that are involved.” -Helen Branswell Senior Writer, Infectious Diseases] ………………………….. January, 2018: Fauci steers massive funding to Wuhan lab’s “gain of function” coronavirus research so a bat disease can spread to humans (and it works) …https://www.naturalnews.com/2023-02-26-lab-to-lungs-real-covid-timeline-in-a-nutshell.html …………………………. • Download PDF Published: 09 November 2015 A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence Vineet D Menachery, Boyd L Yount Jr, Kari Debbink, Sudhakar Agnihothram, Lisa E Gralinski, Jessica A Plante, Rachel L Graham, Trevor Scobey, Xing-Yi Ge, Eric F Donaldson, Scott H Randell, Antonio Lanzavecchia, Wayne A Marasco, Zhengli-Li Shi & Ralph S Baric  Nature Medicine volume 21, pages 1508–1513 (2015) 2.78m Accesses Abstract The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome (MERS)-CoV underscores the threat of cross-species transmission events leading to outbreaks in humans. Here we examine the disease potential of a SARS-like virus, SHC014-CoV, which is currently circulating in Chinese horseshoe bat populations1. Using the SARS-CoV reverse genetics system2, we generated and characterized a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone. The results indicate that group 2b viruses encoding the SHC014 spike in a wild-type backbone can efficiently use multiple orthologs of the SARS receptor human angiotensin converting enzyme II (ACE2), replicate efficiently in primary human airway cells and achieve in vitro titers equivalent to epidemic strains of SARS-CoV. Additionally in vivo experiments demonstrate replication of the chimeric virus in mouse lung with notable pathogenesis. Evaluation of available SARS-based immune-therapeutic and prophylactic modalities revealed poor efficacy; both monoclonal antibody and vaccine approaches failed to neutralize and protect from infection with CoVs using the novel spike protein. On the basis of these findings we synthetically re-derived an infectious full-length SHC014 recombinant virus and demonstrate robust viral replication both in vitro and in vivo. Our work suggests a potential risk of SARS-CoV re-emergence from viruses currently circulating in bat populations. Main The emergence of SARS-CoV heralded a new era in the cross-species transmission of severe respiratory illness with globalization leading to rapid spread around the world and massive economic impact3,4. Since then, several strains—including influenza A strains H5N1, H1N1 and H7N9 and MERS-CoV—have emerged from animal populations, causing considerable disease, mortality and economic hardship for the afflicted regions5. Although public health measures were able to stop the SARS-CoV outbreak4, recent metagenomics studies have identified sequences of closely related SARS-like viruses circulating in Chinese bat populations that may pose a future threat1,6. However, sequence data alone provides minimal insights to identify and prepare for future prepandemic viruses. Therefore, to examine the emergence potential (that is, the potential to infect humans) of circulating bat CoVs, we built a chimeric virus encoding a novel, zoonotic CoV spike protein—from the RsSHC014-CoV sequence that was isolated from Chinese horseshoe bats1—in the context of the SARS-CoV mouse-adapted backbone. The hybrid virus allowed us to evaluate the ability of the novel spike protein to cause disease independently of other necessary adaptive mutations in its natural backbone. Using this approach, we characterized CoV infection mediated by the SHC014 spike protein in primary human airway cells and in vivo, and tested the efficacy of available immune therapeutics against SHC014-CoV. Together the strategy translates metagenomics data to help predict and prepare for future emergent viruses. The sequences of SHC014 and the related RsWIV1-CoV show that these CoVs are the closest relatives to the epidemic SARS-CoV strains (Fig. 1a,b); however, there are important differences in the 14 residues that bind human ACE2, the receptor for SARS-CoV, including the five that are critical for host range: Y442, L472, N479, T487 and Y491 (ref. 7). In WIV1, three of these residues vary from the epidemic SARS-CoV Urbani strain, but they were not expected to alter binding to ACE2 (Supplementary Fig. 1a,b and Supplementary Table 1). This fact is confirmed by both pseudotyping experiments that measured the ability of lentiviruses encoding WIV1 spike proteins to enter cells expressing human ACE2 (Supplementary Fig. 1) and by in vitro replication assays of WIV1-CoV (ref. 1). In contrast, 7 of 14 ACE2-interaction residues in SHC014 are different from those in SARS-CoV, including all five residues critical for host range (Supplementary Fig. 1c and Supplementary Table 1). These changes, coupled with the failure of pseudotyped lentiviruses expressing the SHC014 spike to enter cells (Supplementary Fig. 1d), suggested that the SHC014 spike is unable to bind human ACE2. However, similar changes in related SARS-CoV strains had been reported to allow ACE2 binding7,8, suggesting that additional functional testing was required for verification. Therefore, we synthesized the SHC014 spike in the context of the replication-competent, mouse-adapted SARS-CoV backbone (we hereafter refer to the chimeric CoV as SHC014-MA15) to maximize the opportunity for pathogenesis and vaccine studies in mice (Supplementary Fig. 2a). Despite predictions from both structure-based modeling and pseudotyping experiments, SHC014-MA15 was viable and replicated to high titers in Vero cells (Supplementary Fig. 2b). Similarly to SARS, SHC014-MA15 also required a functional ACE2 molecule for entry and could use human, civet and bat ACE2 orthologs (Supplementary Fig. 2c,d). To test the ability of the SHC014 spike to mediate infection of the human airway we examined the sensitivity of the human epithelial airway cell line Calu-3 2B4 (ref. 9) to infection and found robust SHC014-MA15 replication, comparable to that of SARS-CoV Urbani (Fig. 1c). To extend these findings, primary human airway epithelial (HAE) cultures were infected and showed robust replication of both viruses (Fig. 1d). Together the data confirm the ability of viruses with the SHC014 spike to infect human airway cells and underscore the potential threat of cross-species transmission of SHC014-CoV. Figure 1: SARS-like viruses replicate in human airway cells and produce in vivo pathogenesis.  (a) The full-length genome sequences of representative CoVs were aligned and phylogenetically mapped as described in the Online Methods. The scale bar represents nucleotide substitutions, with only bootstrap support above 70% being labeled. The tree shows CoVs divided into three distinct phylogenetic groups, defined as α-CoVs, β-CoVs and γ-CoVs. Classical subgroup clusters are marked as 2a, 2b, 2c and 2d for the β-CoVs and as 1a and 1b for the α-CoVs. (b) Amino acid sequences of the S1 domains of the spikes of representative β-CoVs of the 2b group, including SARS-CoV, were aligned and phylogenetically mapped. The scale bar represents amino acid substitutions. (c,d) Viral replication of SARS-CoV Urbani (black) and SHC014-MA15 (green) after infection of Calu-3 2B4 cells (c) or well-differentiated, primary air-liquid interface HAE cell cultures (d) at a multiplicity of infection (MOI) of 0.01 for both cell types. Samples were collected at individual time points with biological replicates (n = 3) for both Calu-3 and HAE experiments. (e,f) Weight loss (n = 9 for SARS-CoV MA15; n = 16 for SHC014-MA15) (e) and viral replication in the lungs (n = 3 for SARS-CoV MA15; n = 4 for SHC014-MA15) (f) of 10-week-old BALB/c mice infected with 1 × 104 p.f.u. of mouse-adapted SARS-CoV MA15 (black) or SHC014-MA15 (green) via the intranasal (i.n.) route. (g,h) Representative images of lung sections stained for SARS-CoV N antigen from mice infected with SARS-CoV MA15 (n = 3 mice) (g) or SHC014-MA15 (n = 4 mice) (h) are shown. For each graph, the center value represents the group mean, and the error bars define the s.e.m. Scale bars, 1 mm. Full size image To evaluate the role of the SHC014 spike in mediating infection in vivo, we infected 10-week-old BALB/c mice with 104 plaque-forming units (p.f.u.) of either SARS-MA15 or SHC014-MA15 (Fig. 1e–h). Animals infected with SARS-MA15 experienced rapid weight loss and lethality by 4 d post infection (d.p.i.); in contrast, SHC014-MA15 infection produced substantial weight loss (10%) but no lethality in mice (Fig. 1e). Examination of viral replication revealed nearly equivalent viral titers from the lungs of mice infected with SARS-MA15 or SHC014-MA15 (Fig. 1f). Whereas lungs from the SARS-MA15–infected mice showed robust staining in both the terminal bronchioles and the lung parenchyma 2 d.p.i. (Fig. 1g), those of SHC014-MA15–infected mice showed reduced airway antigen staining (Fig. 1h); in contrast, no deficit in antigen staining was observed in the parenchyma or in the overall histology scoring, suggesting differential infection of lung tissue for SHC014-MA15 (Supplementary Table 2). We next analyzed infection in more susceptible, aged (12-month-old) animals. SARS-MA15–infected animals rapidly lost weight and succumbed to infection (Supplementary Fig. 3a,b). SHC014-MA15 infection induced robust and sustained weight loss, but had minimal lethality. Trends in the histology and antigen staining patterns that we observed in young mice were conserved in the older animals (Supplementary Table 3). We excluded the possibility that SHC014-MA15 was mediating infection through an alternative receptor on the basis of experiments using Ace2−/− mice, which did not show weight loss or antigen staining after SHC014-MA15 infection (Supplementary Fig. 4a,b and Supplementary Table 2). Together, the data indicate that viruses with the SHC014 spike are capable of inducing weight loss in mice in the context of a virulent CoV backbone. Given the preclinical efficacy of Ebola monoclonal antibody therapies, such as ZMApp10, we next sought to determine the efficacy of SARS-CoV monoclonal antibodies against infection with SHC014-MA15. Four broadly neutralizing human monoclonal antibodies targeting SARS-CoV spike protein had been previously reported and are probable reagents for immunotherapy11,12,13. We examined the effect of these antibodies on viral replication (expressed as percentage inhibition of viral replication) and found that whereas wild-type SARS-CoV Urbani was strongly neutralized by all four antibodies at relatively low antibody concentrations (Fig. 2a–d), neutralization varied for SHC014-MA15. Fm6, an antibody generated by phage display and escape mutants11,12, achieved only background levels of inhibition of SHC014-MA15 replication (Fig. 2a). Similarly, antibodies 230.15 and 227.14, which were derived from memory B cells of SARS-CoV–infected patients13, also failed to block SHC014-MA15 replication (Fig. 2b,c). For all three antibodies, differences between the SARS and SHC014 spike amino acid sequences corresponded to direct or adjacent residue changes found in SARS-CoV escape mutants (fm6 N479R; 230.15 L443V; 227.14 K390Q/E), which probably explains the absence of the antibodies' neutralizing activity against SHC014. Finally, monoclonal antibody 109.8 was able to achieve 50% neutralization of SHC014-MA15, but only at high concentrations (10 μg/ml) (Fig. 2d). Together, the results demonstrate that broadly neutralizing antibodies against SARS-CoV may only have marginal efficacy against emergent SARS-like CoV strains such as SHC014. Figure 2: SARS-CoV monoclonal antibodies have marginal efficacy against SARS-like CoVs.  (a–d) Neutralization assays evaluating efficacy (measured as reduction in the number of plaques) of a panel of monoclonal antibodies, which were all originally generated against epidemic SARS-CoV, against infection of Vero cells with SARS-CoV Urbani (black) or SHC014-MA15 (green). The antibodies tested were fm6 (n = 3 for Urbani; n = 5 for SHC014-MA15)11,12 (a), 230.15 (n = 3 for Urbani; n = 2 for SHC014-MA15) (b), 227.15 (n = 3 for Urbani; n = 5 for SHC014-MA15) (c) and 109.8 (n = 3 for Urbani; n = 2 for SHC014-MA15)13 (d). Each data point represents the group mean and error bars define the s.e.m. Note that the error bars in SARS-CoV Urbani–infected Vero cells in b,c are overlapped by the symbols and are not visible. Full size image To evaluate the efficacy of existing vaccines against infection with SHC014-MA15, we vaccinated aged mice with double-inactivated whole SARS-CoV (DIV). Previous work showed that DIV could neutralize and protect young mice from challenge with a homologous virus14; however, the vaccine failed to protect aged animals in which augmented immune pathology was also observed, indicating the possibility of the animals being harmed because of the vaccination15. Here we found that DIV did not provide protection from challenge with SHC014-MA15 with regards to weight loss or viral titer (Supplementary Fig. 5a,b). Consistent with a previous report with other heterologous group 2b CoVs15, serum from DIV-vaccinated, aged mice also failed to neutralize SHC014-MA15 (Supplementary Fig. 5c). Notably, DIV vaccination resulted in robust immune pathology (Supplementary Table 4) and eosinophilia (Supplementary Fig. 5d–f). Together these results confirm that the DIV vaccine would not be protective against infection with SHC014 and could possibly augment disease in the aged vaccinated group. In contrast to vaccination of mice with DIV, the use of SHC014-MA15 as a live, attenuated vaccine showed potential cross-protection against challenge with SARS-CoV, but the results have important caveats. We infected young mice with 104 p.f.u. of SHC014-MA15 and observed them for 28 d. We then challenged the mice with SARS-MA15 at day 29 (Supplementary Fig. 6a). The prior infection of the mice with the high dose of SHC014-MA15 conferred protection against challenge with a lethal dose of SARS-MA15, although there was only a minimal SARS-CoV neutralization response from the antisera elicited 28 d after SHC014-MA15 infection (Supplementary Fig. 6b, 1:200). In the absence of a secondary antigen boost, 28 d.p.i. represents the expected peak of antibody titers and implies that there will be diminished protection against SARS-CoV over time16,17. Similar results showing protection against challenge with a lethal dose of SARS-CoV were observed in aged BALB/c mice with respect to weight loss and viral replication (Supplementary Fig. 6c,d). However, the SHC014-MA15 infection dose of 104 p.f.u. induced >10% weight loss and lethality in some aged animals (Fig. 1 and Supplementary Fig. 3). We found that vaccination with a lower dose of SHC014-MA15 (100 p.f.u.), did not induce weight loss, but it also failed to protect aged animals from a SARS-MA15 lethal dose challenge (Supplementary Fig. 6e,f). Together the data suggest that SHC014-MA15 challenge may confer cross-protection against SARS-CoV through conserved epitopes, but the required dose induces pathogenesis and precludes use as an attenuated vaccine. Having established that the SHC014 spike has the ability to mediate infection of human cells and cause disease in mice, we next synthesized a full-length SHC014-CoV infectious clone based on the approach used for SARS-CoV (Fig. 3a)2. Replication in Vero cells revealed no deficit for SHC014-CoV relative to that for SARS-CoV (Fig. 3b); however, SHC014-CoV was significantly (P < 0.01) attenuated in primary HAE cultures at both 24 and 48 h after infection (Fig. 3c). In vivo infection of mice demonstrated no significant weight loss but showed reduced viral replication in lungs of full-length SHC014-CoV infection, as compared to SARS-CoV Urbani (Fig. 3d,e). Together the results establish the viability of full-length SHC014-CoV but suggest that further adaptation is required for its replication to be equivalent to that of epidemic SARS-CoV in human respiratory cells and in mice. Figure 3: Full-length SHC014-CoV replicates in human airways but lacks the virulence of epidemic SARS-CoV.  (a) Schematic of the SHC014-CoV molecular clone, which was synthesized as six contiguous cDNAs (designated SHC014A, SHC014B, SHC014C, SHC014D, SHC014E and SHC014F) flanked by unique BglI sites that allowed for directed assembly of the full-length cDNA expressing open reading frames (for 1a, 1b, spike, 3, envelope, matrix, 6–8 and nucleocapsid). Underlined nucleotides represent the overhang sequences formed after restriction enzyme cleavage. (b,c) Viral replication of SARS-CoV Urbani (black) or SHC014-CoV (green) after infection of Vero cells (b) or well-differentiated, primary air-liquid interface HAE cell cultures (c) at an MOI of 0.01. Samples were collected at individual time points with biological replicates (n = 3) for each group. Data represent one experiment for both Vero and HAE cells. (d,e) Weight loss (n = 3 for SARS-CoV MA15, n = 7 for SHC014-CoV; n = 6 for SARS-Urbani) (d) and viral replication in the lungs (n = 3 for SARS-Urbani and SHC014-CoV) (e) of 10-week-old BALB/c mice infected with 1 × 105 p.f.u. of SARS-CoV MA15 (gray), SHC014-CoV (green) or SARS-CoV Urbani (black) via the i.n. route…. Overall our approach has used metagenomics data to identify a potential threat posed by the circulating bat SARS-like CoV SHC014. Because of the ability of chimeric SHC014 viruses to replicate in human airway cultures, cause pathogenesis in vivo and escape current therapeutics, there is a need for both surveillance and improved therapeutics against circulating SARS-like viruses. Our approach also unlocks the use of metagenomics data to predict viral emergence and to apply this knowledge in preparing to treat future emerging virus infections…. This paper has been reviewed by the funding agency, the NIH. Continuation of these studies was requested, and this has been approved by the NIH. SARS-CoV is a select agent. All work for these studies was performed with approved standard operating procedures (SOPs) and safety conditions for SARS-CoV, MERs-CoV and other related CoVs. Our institutional CoV BSL3 facilities have been designed to conform to the safety requirements that are recommended in the Biosafety in Microbiological and Biomedical Laboratories (BMBL), the US Department of Health and Human Services, the Public Health Service, the Centers for Disease Control (CDC) and the NIH. Laboratory safety plans were submitted to, and the facility has been approved for use by, the UNC Department of Environmental Health and Safety (EHS) and the CDC. Electronic card access is required for entry into the facility. All workers have been trained by EHS to safely use powered air purifying respirators (PAPRs), and appropriate work habits in a BSL3 facility and active medical surveillance plans are in place. Our CoV BSL3 facilities contain redundant fans, emergency power to fans and biological safety cabinets and freezers, and our facilities can accommodate SealSafe mouse racks. Materials classified as BSL3 agents consist of SARS-CoV, bat CoV precursor strains, MERS-CoV and mutants derived from these pathogens. Within the BSL3 facilities, experimentation with infectious virus is performed in a certified Class II Biosafety Cabinet (BSC). All members of the staff wear scrubs, Tyvek suits and aprons, PAPRs and shoe covers, and their hands are double-gloved. BSL3 users are subject to a medical surveillance plan monitored by the University Employee Occupational Health Clinic (UEOHC), which includes a yearly physical, annual influenza vaccination and mandatory reporting of any symptoms associated with CoV infection during periods when working in the BSL3. All BSL3 users are trained in exposure management and reporting protocols, are prepared to self-quarantine and have been trained for safe delivery to a local infectious disease management department in an emergency situation. All potential exposure events are reported and investigated by EHS and UEOHC, with reports filed to both the CDC and the NIH…. Experiments with the full-length and chimeric SHC014 recombinant viruses were initiated and performed before the GOF research funding pause and have since been reviewed and approved for continued study by the NIH. https://www.nature.com/articles/nm.3985 ……………………….. SHC014-CoV is a SARS-like coronavirus (SL-COV) which infects horseshoe bats (family Rhinolophidae). It was discovered in Kunming in Yunnan Province, China. It was discovered along with SL-CoV Rs3367, which was the first bat SARS-like coronavirus shown to directly infect a human cell line. The line of Rs3367 that infected human cells was named Bat SARS-like coronavirus WIV1.[2] Discovery From April 2011 to September 2012, researchers from the Wuhan Institute of Virology collected 117 anal swabs and fecal samples of bats from a Chinese rufous horseshoe bats (Rhinolophus sinicus) colony in Kunming City (Yunnan Province in south-western China). 27 out of 117 samples (23%) contained seven different isolates of SARS-like coronaviruses, among which were two previously unknown, called RsSHC014 and Rs3367.[2] Virology In 2013 bat SARS-like coronavirus Rs3367 was shown to be able to directly infect the human HeLa cell line. It was the first time that human cells had been infected with a bat SARS-like coronavirus in the lab. The strain of Rs3367 that infected the human cells was named “Bat SARS-like coronavirus WIV”.[2] In 2015 the University of North Carolina at Chapel Hill and the Wuhan Institute of Virology conducted research showing that SHC014 could be made to infect the human HeLa cell line, through the use of reverse genetics to create a chimeric virus consisting of a surface protein of SHC014 and the backbone of a SARS coronavirus.[3][4] The SL-SHC014-MA15 version of the virus, primarily engineered to infect mice, has been shown to differ by over 5,000 nucleotides from SARS-CoV-2, the cause of the COVID-19 pandemic.[5] … See also Bat coronavirus RaTG13 https://en.wikipedia.org/wiki/SHC014-CoV …………………

misqualification of Mother's white light; enchantments

There is a law involved here that states that man is accountable for that which he creates.  Those22 who19 have9 created29 or15 harbored44 a1 rebellious46 spirit37 must10 themselves38 bring32 it11 under26 control34=373 and10 then20 approach42 God17 with24 humility45 (=158; 158 +373= 531) that they too may be received and10 their33 energies46 (=89; 89+531=620= 10 x love received 62) purified.  There is never any question whatsoever concerning the will of God to receive the prodigal son back to His heart.  Therefore no one should make unworthiness an excuse for not engaging in holy prayer.  The worthy need to progress and10 the15 unworthy45 to8 disentangle47 themselves38 from25 enchantments46(=244=4 x iron grip61)

-Jesus Christ, Pearls of Wisdom 11:11  ………………….............................. Beloved ones, there is great God-good in the Earth even as there are great souls in the Earth. These are stalwart ones who have vowed not to be moved from the God-center of the universe nor from the God-center of their hearts. Therefore because you are on your way to your victory we direct you to join together to defeat evil forces, for they22 are15 cunning37. Beware27 of12 them19 (=132=4 x subtleties33) because they have fooled you before else you would not be in this room. On the contrary you would be in the octaves of light but for fallen angels who enticed you here and there and finally caused you to be cast out of Maitreya’s Mystery School. Yes, this is why we speak of evil. It is because evil incarnate has caused you to fail and to fall many times over. For you did not recognize these individuals as evil because they22 pretended46 to8 be7 your25 teachers34 and10 mentors32 (=184=4 x 46; 46=enchantments, pretended) , et cetera. Now then as Jesus said, “Be ye wise as serpents and harmless as doves.” The wisdom of the serpent is the wisdom whereby you raise the sacred fire on your spinal altar. It is indeed the raising of the Kundalini, which fills each chakra with light and brings it into the balance of the universal t’ai chi. And those balanced chakras when filled with light also bring balance to the corresponding organs of the four lower bodies. Observing this increase in light the Lords of Karma in many cases may grant a life extension to worthy souls. Do you understand why you cannot leave Goddess Kundalini ensconced at the base-of-the-spine chakra but rather you must raise her light from the base-of-the-spine chakra to the thousand-petaled lotus of the crown chakra? And that you must do this regularly in deep meditation upon Goddess Kundalini?

-Archangel Zadkiel and Holy Amethyst, via

Elizabeth Clare Prophet on March 29, 1997 at RTR, MT, Pearls of Wisdom 40:33 …………………............................ using numerology here: a=1, b=2, c=3, j=1, etc. misqualification79 of12 Mother’s25 white29 light29=184=4 x 46. dense20 schism26=46; death20 scheme26=46; self-deify46, misguided46; deadly24 coils22=46; shiny30 toys16=46; enchantments46, pretended46, rebellious46. ……………….............. aluminum32 intakes25=57; Teflon27 debris30=57. cooking with this cheap combination, aluminum pans with Teflon, is unhealthy especially for brain cells, also muscles, bones, as such particles leave the pans and transfer via the food cooked. -r. . …………………….....…………………................ ……………………...................

of the Chaldeans of old and reincarnated

      And it shall come to pass when seventy years (possibly 1945-2015) are accomplished that I will punish the king of Babylon and that nation, saith the Lord, for their iniquity, and the land of the Chaldeans, and will make it perpetual desolations.       And I will bring upon that land all my words which I have pronounced against it, even all that is written in this book, which Jeremiah hath prophesied against all the nations.

-Gautama Buddha, Pearl 26:39 …………....................... And realize the fullness and portent of my message. For it shall come to pass. For I AM the Lord of the World and I am sent by God to announce to you the message of the lilies of the field. “The lilies of the field, they toil not, neither do they spin. Yet I tell you that Solomon in all his glory is not arrayed as one of these.” Chelas of the living fire of the Mother and the Buddha, so seek thy raiment in the whiteness of the lily and be arrayed in the glory of thy Christhood. Under the canopy of the Buddha so grow and fulfill purity’s destiny…. I AM the Mother’s purity forever and forever and forever. Aum Buddha Aum Shamballa the Magnificent, I love thee! The Lord hath a controversy with the nation         …Moreover I will take from them the voice of mirth and the voice of gladness, the voice of the bridegroom and the voice of the bride, the sound of the millstones and the light of the candle. And this whole land shall be a desolation and an astonishment; and these nations shall serve the king of Babylon seventy years.       And it shall come to pass when seventy years are accomplished that I will punish the king of Babylon and that nation, saith the Lord, for their iniquity, and the land of the Chaldeans, and will make it perpetual desolations.       And I will bring upon that land all my words which I have pronounced against it, even all that is written in this book, which Jeremiah hath prophesied against all the nations.       For many nations and great kings shall serve themselves of them also: and I will recompense them according to their deeds, and according to the works of their own hands.       For thus saith the LordGod of Israel unto me: Take the wine cup of this fury at my hand and cause all the nations, to whom I send thee to drink it. And they shall drink and be moved and be mad, because of the sword that I will send among them.       Then took I the cup at the Lord’s hand and made all the nations to drink, unto whom the Lord had sent me: to wit, Jerusalem and the cities of Judah and the kings thereof, and the princes thereof, to make them a desolation, an astonishment, an hissing and a curse; as it is this day;… -read out by the Messenger by direction of Gautama), Pearl 26:39 …………………............................. Note well, my beloved, the process–the sacred ritual–of the path of ruby ray as its fiery coil unwinds in the life of Ezekiel. Five hundred years before the birth of the Messiah, Ezekiel was a priest, the son of Buzi in the land of the Chaldeans (Babylon). He was the priest who became the prophet, and his commission to the whole house of Israel began with the appearance of the I AM Presence and Four Cosmic Forces. Before his mission was accomplished he would himself experience the putting on of the four faces of Christ which appeared to him. The Lord’s appearance to him is an exercise of His freewill to enter time and space in what modern man would call an exception to the laws of material science. Certainly this appearance would not be subject to empirical proof by material science, but just as certainly it is wholly verifiable in the empirical proof of spiritual science demonstrated daily by souls who are of the light. -Sanat Kumara, Pearl 22:22 ……..…………………..................... By the dispensation of Saint Germain and Goddess of Liberty freedom of religion has been guaranteed in America even though that guarantee has been violated horrendously by kidnappings, by deprogrammings, reprogrammings and brainwashing and by all manner of treachery and intrigue. Thus [you see] the movements of the Chaldeans and black priests of Atlantis come again to snuff out the true path of Saint Germain and Jesus Christ. They come to turn the people against that path, and the people unwittingly follow them and know not that in following them they are again rejecting the mighty one of old, the living Jesus Christ, the great emperor of the golden age of Atlantis. -Rai Ernon of Suern (old India), Pearls of Wisdom 34:61 ………………………........................... In the name of the light of God that never fails I call forth the intense action of beloved Elohim Cyclopea. I call forth the great expansion of the God-flame. I call forth the light of ten thousand suns—Elohim of God and Great Silent Watchers holding the immaculate concept with the Cosmic Christ for our lifewave, for our evolution, for the root races of planet Earth, for the I AM race of Sanat Kumara in whom there dwells the Mighty I AM Presence and threefold flame. In the name of the Father and of the Son and of the Holy Spirit, in the name of the Mother I invoke the presence here of the Seven Holy Kumaras, Mighty Victory and legions of light, beloved Omri-Tas and 144,000 priests of the sacred fire from the very heart of the Violet Planet. I call forth the action now! Blaze the light of Elohim Cyclopea! Blaze the light of the all-seeing Eye of God for the vision of our fiery destiny! I call forth the vision of our fiery destiny now. I call it forth in the name of the entire Spirit of the Great White Brotherhood and the World Mother. And let it be done in the name I AM THAT I AM. Amen.The Word of the Lord unto Ezekiel the Priest (Messenger reads:) In the fifth day of the month, which was the fifth year of king Jehoiachin’s captivity, The word of the Lord—the word of the I AM THAT I AM Sanat Kumara—came expressly unto Ezekiel the priest, the son of Buzi in the land of the Chaldeans by the river Chebar; and the hand of the Lord was there upon him.... And he said unto me, Son of man, stand upon thy feet, and I will speak unto thee.

-Elohim Cyclopea, Pearl 25:40 ……………............................ In order for you to demonstrate this same principle of eternal life through the Mother- flame it is the requirement of the Law that the sacred fire within you be not squandered in any of misuses of the life-force forbidden by cosmic law in the Garden of Eden. Therefore you can understand why the head of these serpents is ever determined to bruise the heel of the Christed ones. The heel is the symbol not only of the reproductive organs but also of the genes and chromosomes and DNA spiral which conveys in matter the Christic light sealed in the seed and egg of man and woman. Inroads into the very light of the soul itself are being attempted once again by reembodied Atlantean scientists–serpents in your midst who contemplate the submission of the entire human race to their devilish designs (all in the guise of good) through alteration of the genetic code, selective breeding of the seed of Serpent with the seed of Christ to produce a supposed superior race having the cunning of the fallen ones enhanced by the light of the Woman. They also contemplate behavior modification for mankind’s passive role-playing in the perverted matrices of Serpent and, of course, euthanasia, misnamed ‘mercy killing’, and the abortion of the life of the innocents in the womb of the Mother. They shall not pass! By the God-mastery of this life-force in my sons and daughters they shall go forth as initiates of the ruby ray, as overcomers not to be overcome by the temptations–so blatantly portrayed in the media–to misuse the sacred fire of the Mother in scientific as well as sexual misqualifications and perversions. Let the Christed ones use the heel–symbol of their Aquarian God-love as well as their Piscean God-mastery–once and for all to bruise and destroy the many-headed serpents of the last days. They shall not pass! For the path of the ruby ray is the path of your soul’s accelerated God-mastery of the accelerated God-love of the Holy Spirit. Awake, awake ye sons and daughters of light!  Awake, put on strength, thou who art the arm of the Lord in all the Earth!  Awake, as in the ancient days when thou camest in the generations of old with the Ancient of Days vowing to save the Woman and her seed!  Art thou not the band of chosen ones that hath cut Rahab to ribbons and wounded the dragon to death?

-Sanat Kumara, Pearls of Wisdom 22:46 …………...........................